Search

Search Results

• COMMENT TO THE ARTICLE PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS. BY KOREN ET AL.

  Antonio Amato

  e2014021

  2014-03-10

  https://doi.org/10.4084/mjhid.2014.021

  1277

  PDF: 772

  HTML: 2373

• CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

  Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi

  e2010017

  2010-06-18

  https://doi.org/10.4084/mjhid.2010.017

  1599

  PDF: 697

  HTML: 2326

• A A RETROSPECTIVE LONG-TERM STUDY ON AGE AT MENARCHE AND MENSTRUAL CHARACTERISTICS IN 85 YOUNG WOMEN WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (TDT) BORN BETWEEN 1965 AND 1995 Long-Term Study on Age at Menarche and Menstrual Characteristics in patients with TDT

  Vincenzo De Sanctis, Salvatore Di Maio

  e2021040

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.040

  1429

  PDF: 455

  HTML: 161

• EARLY APPLICATION OF HIGH CUT-OFF HAEMODYALISIS FOR DE-NOVO MYELOMA NEPHROPATHY IS ASSOCIATED WITH LONG-TERM DIALYSIS-INDEPENDENCY AND RENAL RECOVERY

  Alhossain A. Khalafallah, Sie Wuong Loi, Sarah Love, Muhajir B. Mohamed, Rose Mace, Ramy Khalil, Miriam Girgs, Rajesh Raj, Mathew Mathew

  e2013007

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.007

  1286

  PDF: 633

  HTML: 2472

  cover letter: 179

• RITUXIMAB VERSUS SPLENECTOMY IN CHRONIC PRIMARY ITP: EXPERIENCE OF A SINGLE HEMATOLOGY CLINIC

  Rawanda Shamoon, Ahmed K. Yassin, Sara L. Alnuaimi

  e2024019

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.019

  972

  PDF: 1111

  HTML: 65

• Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

  Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti

  e2022043

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.043

  1252

  PDF: 539

  HTML: 203

• How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency

  Marco Sanna, Giovanni Caocci, Giorgio La Nasa

  e2017047

  2017-08-14

  https://doi.org/10.4084/mjhid.2017.047

  1770

  PDF: 874

  HTML: 930

  Referring article: 715

• The diagnostic approach to central adrenocortical insufficiency (CAI) in thalassemia

  Vincenzo De Sanctis, Heba Elsedfy, Ashraf T Soliman

  e2016026

  2016-05-01

  https://doi.org/10.4084/mjhid.2016.026

  3032

  PDF: 768

  HTML: 2745

• PLATELET-LEUKOCYTE INTERACTIONS : MULTIPLE LINKS BETWEEN INFLAMMATION , BLOOD COAGULATION AND VASCULAR RISK

  Chiara Cerletti, Giovanni de Gaetano, Roberto Lorenzet

  e2010023

  2010-08-06

  https://doi.org/10.4084/mjhid.2010.023

  1675

  PDF: 807

  HTML: 10360

• MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus

  Emanuele Focà, Silvia Odolini, Nigritella Brianese, Gianpiero Carosi

  e2012032

  2012-05-07

  https://doi.org/10.4084/mjhid.2012.032

  2610

  PDF: 957

  HTML: 2151

• VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

  Francesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini

  e2009033

  2009-12-29

  https://doi.org/10.4084/mjhid.2009.033

  2543

  PDF: 478

  HTML: 3433

• Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

  Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan

  e2016050

  2016-10-20

  https://doi.org/10.4084/mjhid.2016.050

  2706

  PDF: 721

  HTML: 1241

  Blood Count trend before and during lenalidomide treatment: 150

  Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 166

• ON THE VERSATILITY OF VON WILLEBRAND FACTOR

  Antoine Rauch, Peter Lenting

  e2013046

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.046

  2726

  PDF: 1078

  HTML: 11204

• Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs

  Feiying Meng

  e2021041

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.041

  1058

  PDF: 452

  HTML: 211

• TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment

  Alessandro Buonomo, Eleonora Nucera, Marianna Criscuolo

  e2022040

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.040

  1952

  PDF: 1451

  HTML: 256

• The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases

  Laila Al Yazidi

  e2020074

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.074

  759

  PDF: 658

  HTML: 290

• Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

  matteo molica, Fulvio Massaro, Giorgia Annechini, Erminia Baldacci, Gianna maria D'elia, Riccardo Rosati, Silvia maria trisolini, Paola Volpicelli, Robin Foà, Saveria Capria

  e2016020

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.020

  3343

  PDF: 954

  HTML: 2299

• Genetic modulators of diversity in biological expression of sickle cell anemia in patients from democratic republic of Congo

  MAMY NGOLE, MAMY NGOLE, GLOIRE MBAYABO, PAUL LUMBALA, VALERIE RACE, NONO MVUAMA, STEPHANIE DEMAN, ERIKA SOUCHE, PROSPER TSHILOBO LUKUSA, CHRIS VAN GEET, KOENRAAD DEVRIENDT, GERT MATTHIJS, AIME LUMAKA, ISABELLE CLEYNEN

  e2025001

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.001

  1595

  HTML: 216

  PDF: 1177

• MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

  Alfredo Marzano

  e2009025

  https://doi.org/10.4084/mjhid.2009.025

  800

  PDF: 477

  HTML: 1282

• MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

  Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo

  e2025064

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.064

  1818

  PDF: 737

  HTML: 152

• THE CHALLENGE OF AML IN OLDER PATIENTS

  Alan K Burnett

  e2013038

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.038

  2117

  PDF: 913

  HTML: 2143

• West Nile Virus Encephalitis in A Patient with Chronic Lymphocytic Leukemia

  Giovanni D'Arena, Carmela Palladino, Michele Bosco, Michele Gambardella

  e2025010

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.010

  1297

  PDF: 1055

  HTML: 140

• A novel ALAS2 mutation causes congenital sideroblastic anemia

  Kun Yang

  e2023062

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.062

  596

  PDF: 473

  HTML: 123

• Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia

  Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Devika Gupta

  e2013042

  2013-06-04

  https://doi.org/10.4084/mjhid.2013.042

  2705

  PDF: 928

  HTML: 3100

  flowcytometric result of peripheral blood sample: 155

• OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

  Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz

  e2012011

  2012-02-10

  https://doi.org/10.4084/mjhid.2012.011

  1015

  PDF: 524

  HTML: 1670

  Figures: 140

  Fifures Sanz: 155

  tables Sanz: 163

  Untitled: 155

• Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Complicated by c: A Case Report

  Yu Chen, Jin Zhang, wenqiang kong

  e2026005

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.005

  453

  PDF: 311

  HTML: 73

• CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment

  Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori

  e2019048

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.048

  1847

  PDF: 1121

  HTML: 247

• Association of the SOD2 polymorphism (Val6Ala) and SOD activity with vaso-occlusive crisis and acute splenic sequestration in children with sickle cell anemia

  Isabela Cristina Cordeiro Farias, Taciana Furtado Mendonça-Belmont, Andreia Soares Silva, Kleyton Palmeira do Ó, Felipe Borba Ferreira, Fernanda Silva Medeiros, Luydson Richardson Silva Vasconcelos, Moacyr Jesus Barreto de Melo Rego, Marcos Andre Cavalcanti Bezerra, Aderson Silva Araujo, Patricia Muniz Mendes Freire Moura, Ana Claudia Mendonça Anjos, Betânia Lucena Domingues Hatzlhofer, Maria do Socorro Mendonça Cavalcanti

  e2018012

  2018-02-21

  https://doi.org/10.4084/mjhid.2018.012

  2909

  PDF: 908

  HTML: 386

• ZIKA VIRUS: A REVIEW FROM THE VIRUS BASICS TO PROPOSED MANAGEMENT STRATEGIES

  Lorenzo Zammarchi, Michele Spinicci, Alessandro Bartoloni

  e2016056

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.056

  4247

  PDF: 1177

  HTML: 2040

• EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

  Eduardo Magalhães Rego, Rafael Henriques Jácomo

  e2011049

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.049

  2581

  PDF: 967

  HTML: 2545

• MOLECULAR CHARACTERIZATION OF EPSTEIN - BARR VIRUS BASED ON EBNA3C PROTEIN AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS IN JORDAN

  Rabaa Athamneh, Hiba Swaity, Waleed Almomani, Hayyan. Taweil , Assia Benbraiek, Anas Khalifeh

  e2025032

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.032

  743

  PDF: 694

  HTML: 95

• PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

  Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli

  e2019015

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.015

  1749

  PDF: 947

  HTML: 286

• POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

  Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles

  e2010016

  2010-06-19

  https://doi.org/10.4084/mjhid.2010.016

  1129

  PDF: 710

  HTML: 567

• IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

  Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica

  e2021062

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.062

  1133

  PDF: 436

  HTML: 139

• Clinical Profile of Dengue Infection in Patients with Hematological Diseases

  Sanjeev Kumar Sharma, Tulika Seth, Pravas Mishra, Nitin Gupta, Narendra Agrawal, Shobha Broor, Manoranjan Mahapatra, Renu Saxena

  e2011039

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.039

  1540

  PDF: 744

  HTML: 1730

• COMPARATIVE STUDY ON THE MEASUREMENT OF LIVER T2* VALUES OF THALASSEMIA PATIENTS AND THE CLINICAL GRADING OF LIVER IRON CONCENTRATION BY DIFFERENT POST-PROCESSING SOFTWARE MEASUREMENT OF LIVER T2* VALUES OF THALASSEMIA

  Peng Peng, Fengming XU, Jixing YI, Bumin LIANG, Cheng TANG, Qing FENG

  e2022072

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.072

  743

  PDF: 550

  HTML: 185

• SURVIVAL PROBABILITY IN PATIENTS WITH SICKLE CELL ANEMIA USING THE COMPETITIVE RISK STATISTICAL MODEL

  Samir Ballas, Emilia Matos do Nascimento, PhD, Clarisse Lopes de Castro Lobo, MD, Basilio de Bragança Pereira, PhD

  e2019022

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.022

  1450

  PDF: 892

  HTML: 182

• Graves’ disease thyrotoxicosis and propylthiouracil related agranulocytosis successfully treated with therapeutic plasma exchange and g-csf followed by total thyroidectomy.

  Anna Candoni

  e2017058

  2017-10-16

  https://doi.org/10.4084/mjhid.2017.058

  2826

  PDF: 839

  HTML: 1397

  Fig.1: 148

  Fig.2: 155

• THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti

  e2013027

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.027

  2054

  PDF: 1003

  HTML: 2682

• Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

  Giuseppe Leone, Luigi Maria Larocca, Eligio Pizzigallo

  e2009001

  2009-06-22

  3262

  PDF: 562

  HTML: 628

• Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia

  Marco Andreani, Manuela Testi, Pietro Sodani, Maria Troiano, Andrea Di Luzio, Giuseppe Testa, Michela Falco, Elvira Poggi, Javid Gaziev, Antonina Piazza

  e2017020

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.020

  2847

  PDF: 923

  HTML: 518

• Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy

  Gianluca Cavallaro

  e2024049

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.049

  2159

  HTML: 126

  PDF: 1069

• PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas

  Manal Alsaif, Joan Robinson, Moshtag Abdulbaqi, Mustafa Aghbari, Khalid Al Noaim, Muneera Alabdulqader

  e2021002

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.002

  1405

  PDF: 530

  HTML: 196

• AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA

  Femi Akodu, I N Diaku-Akinwumi, O F Njokanma

  e2013001

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.001

  1914

  PDF: 846

  HTML: 1840

• THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

  Xenofon Papanikolaou, Bart Barlogie, Saad Usmani

  e2011047

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.047

  2393

  PDF: 755

  HTML: 1719

• The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT SOD and SCD in Egypt

  Mervat Khorshied, Iman A, Shaheen, Yasmeen M.M Selim, Asmaa O. Elshahawy, Ilham Youssry

  e2022037

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.037

  1032

  PDF: 546

  HTML: 373

• BONE MINERAL DENSITY AND VITAMIN D RECEPTOR GENETIC VARIANTS IN EGYPTIAN CHILDREN WITH BETA THALASSEMIA ON VITAMIN D SUPPLEMENTATION

  Hadeer A Abbassy, Reham Abdel Haleem Abo Elwafa, Omneya Magdy Omar

  e2019013

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.013

  2179

  PDF: 1183

  HTML: 200

• A POPULATION-BASED STUDY ON MYELODYSPLASTIC SYNDROMES IN THE LAZIO REGION (ITALY), MEDICAL MISCODING AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

  Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, Anna Lina Piccioni, Agostino Tafuri, Giulio Trapè, Alessandro Andriani, Paolo De Fabritis, Maria Teresa Voso, Marina Davoli, Gina Zini

  e2017046

  2017-07-01

  https://doi.org/10.4084/mjhid.2017.046

  2540

  PDF: 949

  HTML: 1092

• Anemia in the elderly: not always what it seems.

  Marco Cerrano, Elena Crisà, Valentina Giai, Mario Boccadoro, Dario Ferrero

  e2016017

  2016-02-25

  https://doi.org/10.4084/mjhid.2016.017

  3225

  PDF: 985

  HTML: 1751

  Figure 1: 156

  Figure 1 revised: 159

• Bacillus Cereus catheter related bloodstream infection in a patient in a patient with acute lymphblastic leukemia

  Lütfiye Öksüz, N Gurler, M Muftuoglu, FD Sargin, SK Besisik

  e2012004

  2012-01-18

  https://doi.org/10.4084/mjhid.2012.004

  1507

  PDF: 1053

  HTML: 1050